141 related articles for article (PubMed ID: 37641501)
1. Severe skin infections.
Windsor C; Urbina T; de Prost N
Curr Opin Crit Care; 2023 Oct; 29(5):407-414. PubMed ID: 37641501
[TBL] [Abstract][Full Text] [Related]
2. Impact of Empiric Linezolid for Necrotizing Soft Tissue Infections on Duration of Methicillin-Resistant
Lehman A; Santevecchi BA; Maguigan KL; Laconi N; Loftus TJ; Mohr AM; Shoulders BR
Surg Infect (Larchmt); 2022 Apr; 23(3):313-317. PubMed ID: 35133888
[No Abstract] [Full Text] [Related]
3. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.
Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H
Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257
[TBL] [Abstract][Full Text] [Related]
4. Interventions for necrotizing soft tissue infections in adults.
Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.
Horn DL; Roberts EA; Shen J; Chan JD; Bulger EM; Weiss NS; Lynch JB; Bryson-Cahn C; Robinson BRH
Clin Infect Dis; 2021 Dec; 73(11):e4592-e4598. PubMed ID: 33151283
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics in Necrotizing Soft Tissue Infections.
Urbina T; Razazi K; Ourghanlian C; Woerther PL; Chosidow O; Lepeule R; de Prost N
Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572686
[TBL] [Abstract][Full Text] [Related]
7. Regional Variations in Microbiology and Outcomes of Necrotizing Soft Tissue Infections: A Systematic Review and Meta-Analysis.
Dhanasekara CS; Marschke B; Morris E; Kahathuduwa CN; Dissanaike S
Surg Infect (Larchmt); 2022 Sep; 23(7):634-644. PubMed ID: 35904966
[No Abstract] [Full Text] [Related]
8. Essentials in the management of necrotizing soft-tissue infections.
Jung N; Eckmann C
Infection; 2019 Aug; 47(4):677-679. PubMed ID: 31077024
[TBL] [Abstract][Full Text] [Related]
9. Microbiological Etiology of Necrotizing Soft Tissue Infections.
Skrede S; Bruun T; Rath E; Oppegaard O
Adv Exp Med Biol; 2020; 1294():53-71. PubMed ID: 33079363
[TBL] [Abstract][Full Text] [Related]
10. Using clinical pathways to aid in the diagnosis of necrotizing soft tissue infections synthesis of evidence.
Schuster L; Nuñez DE
Worldviews Evid Based Nurs; 2012 Apr; 9(2):88-99. PubMed ID: 22151905
[TBL] [Abstract][Full Text] [Related]
11. Cervical Necrotizing Fasciitis, Diagnosis and Treatment of a Rare Life-Threatening Infection.
Hua J; Friedlander P
Ear Nose Throat J; 2023 Mar; 102(3):NP109-NP113. PubMed ID: 33570428
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection.
Dorazio J; Chiappelli AL; Shields RK; Tsai YV; Skinker P; Nabozny MJ; Bauza G; Forsythe R; Rosengart MR; Gunn SR; Marini R; Clarke L; Falcione B; Ludwig J; McCreary EK
Open Forum Infect Dis; 2023 Jun; 10(6):ofad258. PubMed ID: 37351452
[TBL] [Abstract][Full Text] [Related]
13. Aggressive Soft Tissue Infections.
Garcia NM; Cai J
Surg Clin North Am; 2018 Oct; 98(5):1097-1108. PubMed ID: 30243450
[TBL] [Abstract][Full Text] [Related]
14. Wound Culture Utility in Negative Surgical Exploration for Necrotizing Soft Tissue Infection.
Howell EC; Keeley JA; Woods AL; Kaji AH; Deane MR; Kim DY; Neville AL
Am Surg; 2019 Oct; 85(10):1175-1178. PubMed ID: 31657319
[TBL] [Abstract][Full Text] [Related]
15. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
Cortés-Penfield N; Ryder JH
Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
[TBL] [Abstract][Full Text] [Related]
16. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
Turina M; Cheadle WG
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
[TBL] [Abstract][Full Text] [Related]
17. Determinants of mortality for necrotizing soft-tissue infections.
McHenry CR; Piotrowski JJ; Petrinic D; Malangoni MA
Ann Surg; 1995 May; 221(5):558-63; discussion 563-5. PubMed ID: 7748037
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection.
George ME; Rueth NM; Skarda DE; Chipman JG; Quickel RR; Beilman GJ
Surg Infect (Larchmt); 2009 Feb; 10(1):21-8. PubMed ID: 18991520
[TBL] [Abstract][Full Text] [Related]
19. [Necrotizing soft tissue infections: role of the localization for the antibiotic management].
Wattel F; Mathieu D; Neut C; Dubreuil L; Cesari JF; Favory R
Bull Acad Natl Med; 2004; 188(3):473-86; discussion 486-90. PubMed ID: 15584657
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing skin and soft-tissue infections in the intensive care unit.
Peetermans M; de Prost N; Eckmann C; Norrby-Teglund A; Skrede S; De Waele JJ
Clin Microbiol Infect; 2020 Jan; 26(1):8-17. PubMed ID: 31284035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
